Latest Breaking News On - Senti biosciences inc - Page 1 : vimarsana.com

2,537,558 Shares in Senti Biosciences, Inc (NASDAQ:SNTI) Bought by 8Vc Gp I LLC

8Vc Gp I LLC bought a new position in shares of Senti Biosciences, Inc. (NASDAQ:SNTI – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 2,537,558 shares of the company’s stock, valued at approximately $1,675,000. Senti Biosciences makes up about 1.7% of 8Vc Gp […]

Vc gpSenti biosciences incInvestment managementSenti biosciencesFree reportBiosciences stock downGet free reportVisit holdingschannelSenti biosciences daily

Senti Biosciences (NASDAQ:SNTI) Shares Down 3 5%

Shares of Senti Biosciences, Inc. (NASDAQ:SNTI – Get Free Report) traded down 3.5% during trading on Wednesday . The stock traded as low as $0.36 and last traded at $0.36. 43,559 shares traded hands during mid-day trading, a decline of 64% from the average session volume of 120,647 shares. The stock had previously closed at […]

Senti biosciences incInvestment managementSenti biosciences company profileSenti biosciencesGet free reportFree reportSenti biosciences daily

Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia

Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesKanya rajangamSecurities exchangeSenti biosciences incHead of research developmentExchange commissionLogic gatedGene circuitChief medical officerSenti bioGene circuitsSpark therapeuticsSecurities actSecurities exchange actQuarterly reportSenti biosciences

Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the

Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

United statesKanya rajangamHead of research developmentExchange commissionSenti biosciences incSecurities exchangeLogic gatedGene circuitChief medical officerSenti bioGene circuitsSpark therapeuticsSecurities actSecurities exchange actQuarterly reportSenti biosciences

Contrasting Senti Biosciences (NASDAQ:SNTI) and AlloVir (NASDAQ:ALVR)

Contrasting Senti Biosciences (NASDAQ:SNTI) and AlloVir (NASDAQ:ALVR)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesSouth san franciscoViracyte incSenti biosciences incAllovir incCelest therapeutics shanghai coSenti biosciencesGet free reportGiven allovirLogic gatedTumor associated antigenProtective antigen paired discovery platformCelest therapeuticsSenti biosciences daily